Detalles de la búsqueda
1.
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
Harm Reduct J
; 19(1): 77, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836189
2.
"It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.
J Urban Health
; 98(1): 59-69, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118145
3.
"If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs.
Harm Reduct J
; 18(1): 65, 2021 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34162375
4.
A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.
Am J Public Health
; 110(6): 833-835, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298171
5.
A low-barrier, flexible safe supply program to prevent deaths from overdose.
CMAJ
; 194(19): E674-E676, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577374
6.
Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemic.
Can Fam Physician
; 68(2): 109-111, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177500
7.
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report.
CMAJ
; 192(5): E115-E117, 2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015080
8.
Impact of unstable housing on all-cause mortality among persons who inject drugs.
BMC Public Health
; 15: 106, 2015 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884182
9.
From methadone to Methadose: Lessons learned from methadone formulation change in British Columbia.
Can Fam Physician
; 66(11): 797-798, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208417
10.
De la méthadone à la Méthadose: Leçons apprises d'un changement dans la formulation de la méthadone en Colombie-Britannique.
Can Fam Physician
; 66(11): e273-e275, 2020 11.
Artículo
en Francés
| MEDLINE | ID: mdl-33208436
11.
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.
CMAJ
; 191(38): E1049-E1056, 2019 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31548191
12.
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study.
Subst Abuse Treat Prev Policy
; 19(1): 14, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383467
13.
Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program Study.
Int J Drug Policy
; 122: 104244, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950943
14.
Does evidence support supervised injection sites?
Can Fam Physician
; 63(11): 866, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138158
15.
Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?
J Addict Med
; 16(3): 258-260, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34145188
16.
"COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada.
Int J Drug Policy
; 106: 103742, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35679695
17.
Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocol.
BMJ Open
; 12(9): e067608, 2022 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167365
18.
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans.
CMAJ Open
; 9(1): E115-E124, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33622764
19.
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case Series.
J Addict Med
; 14(5): 437-440, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011407
20.
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case series.
Drug Alcohol Rev
; 39(5): 588-594, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657496